ADWOA AMPONSAH-POKU: Open Payments
NPI 1124736939 · LA PLATA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 17 payments from 6 companies in 2025. Trend: 2023 $119 · 2024 $358 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $188 |
| Lilly USA, LLC | 3 | $69 |
| Novo Nordisk Inc | 2 | $45 |
| Medtronic, Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: OTEZLA, MOUNJARO, Wegovy, SIGNIA, QULIPTA, ZEPBOUND, Veozah.
Industry payments across MD — which companies pay providers there.
